Price T Rowe Associates Inc Care Dx, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 29,396 shares of CDNA stock, worth $438,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,396
Previous 27,052
8.66%
Holding current value
$438,000
Previous $325,000
4.0%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CDNA
# of Institutions
150Shares Held
55.1MCall Options Held
85.8KPut Options Held
48.8K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.86MShares$87.4 Million0.44% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$80.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.3MShares$64.1 Million0.0% of portfolio
-
State Street Corp Boston, MA4.2MShares$62.5 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.93MShares$58.6 Million0.65% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $797M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...